Literature DB >> 26751902

Clinical implementation of pharmacogenetics.

Xandra García-González, Teresa Cabaleiro, María José Herrero, Howard McLeod, Luis A López-Fernández.   

Abstract

In the last decade, pharmacogenetic research has been performed in different fields. However, the application of pharmacogenetic findings to clinical practice has not been as fast as desirable. The current situation of clinical implementation of pharmacogenetics is discussed. This review focuses on the advances of pharmacogenomics to individualize cancer treatments, the relationship between pharmacogenetics and pharmacodynamics in the clinical course of transplant patients receiving a combination of immunosuppressive therapy, the needs and barriers facing pharmacogenetic clinical application, and the situation of pharmacogenetic testing in Spain. It is based on lectures presented by speakers of the Clinical Implementation of Pharmacogenetics Symposium at the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society, held in April 20, 2015.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26751902     DOI: 10.1515/dmpt-2015-0031

Source DB:  PubMed          Journal:  Drug Metab Pers Ther        ISSN: 2363-8915


  10 in total

Review 1.  Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.

Authors:  Simona Volpi; Carol J Bult; Rex L Chisholm; Patricia A Deverka; Geoffrey S Ginsburg; Howard J Jacob; Melpomeni Kasapi; Howard L McLeod; Dan M Roden; Marc S Williams; Eric D Green; Laura Lyman Rodriguez; Samuel Aronson; Larisa H Cavallari; Joshua C Denny; Lynn G Dressler; Julie A Johnson; Teri E Klein; J Steven Leeder; Micheline Piquette-Miller; Minoli Perera; Laura J Rasmussen-Torvik; Heidi L Rehm; Marylyn D Ritchie; Todd C Skaar; Nikhil Wagle; Richard Weinshilboum; Kristin W Weitzel; Robert Wildin; John Wilson; Teri A Manolio; Mary V Relling
Journal:  Clin Pharmacol Ther       Date:  2018-03-30       Impact factor: 6.875

Review 2.  Metagenomics and chemotherapy-induced nausea: A roadmap for future research.

Authors:  Sylvia L Crowder; Aasha I Hoogland; Taylor L Welniak; Elizabeth A LaFranchise; Kristen M Carpenter; Daneng Li; Daniel M Rotroff; Arshiya Mariam; Christine M Pierce; Stacy M Fischer; Anita Y Kinney; Thi Dong-Binh Tran; Farzaneh Rastegari; Donna L Berry; Martine Extermann; Richard D Kim; Danielle B Tometich; Jane C Figueiredo; Jameel Muzaffar; Shahla Bari; Kea Turner; George M Weinstock; Heather S L Jim
Journal:  Cancer       Date:  2021-10-13       Impact factor: 6.860

Review 3.  Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.

Authors:  Alessio Ardizzone; Anna Paola Capra; Michela Campolo; Alessia Filippone; Emanuela Esposito; Silvana Briuglia
Journal:  Biomedicines       Date:  2022-04-19

4.  Influence of ABCB1 gene polymorphism on concentration to dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients.

Authors:  Fahad Azam; Moosa Khan; Tanwir Khaliq; Abu Bakar Hafeez Bhatti
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

5.  Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.

Authors:  Joseph Finkelstein; Carol Friedman; George Hripcsak; Manuel Cabrera
Journal:  Pharmgenomics Pers Med       Date:  2016-10-14

6.  Editorial: Translation of Genomic Results Into Public Health Practice.

Authors:  Natasa Djordjevic; Stefania Boccia; Róza Ádány
Journal:  Front Public Health       Date:  2018-05-25

Review 7.  Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials.

Authors:  Danielle Johnson; Dyfrig Hughes; Munir Pirmohamed; Andrea Jorgensen
Journal:  J Pers Med       Date:  2019-09-01

Review 8.  Pharmacogenetics implementation in the clinics: information and guidelines for germline variants.

Authors:  Gladys Olivera; Luis Sendra; María José Herrero; Pablo Berlanga; Pablo Gargallo; Yania Yáñez; Andrea Urtasun; Jaime Font de Mora; Victoria Castel; Adela Cañete; Salvador F Aliño
Journal:  Cancer Drug Resist       Date:  2019-03-19

9.  Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients.

Authors:  Fahad Azam; Moosa Khan; Abida Shaheen; AbuBakar Hafeez Bhatti
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

10.  The Cyp2b6 Gene Polymorphism and Phenotypic Correlation of Efavirenz-Based Combination Therapy Among the Niger Delta Ethnic Population: Implications in Modern Pharmacogenomics.

Authors:  Samuel J Bunu; Azibanasamesa D C Owaba; Edebi N Vaikosen; Benjamin U Ebeshi
Journal:  Pharmgenomics Pers Med       Date:  2022-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.